Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ahring, DK
Birgitte Kiaer Ahring, Horsholm DK
| Patent application number | Description | Published |
|---|---|---|
| 20090258404 | PRODUCTION OF FERMENTATION PRODUCTS IN BIOFILM REACTORS USING MICROORGANISMS IMMOBILISED ON STERILISED GRANULAR SLUDGE - Production of fermentation products, such as ethanol and lactic acid in biofilm reactors by microorganisms immobilised on sterilised granular sludge. | 10-15-2009 |
| 20100143988 | THERMOANAEROBACTER MATHRANII STRAIN BG1 - Strict anaerobic thermophilic bacterium belonging to the group of | 06-10-2010 |
Birgitte Kiaer Ahring, Hoersholm DK
| Patent application number | Description | Published |
|---|---|---|
| 20080217249 | METHOD AND EQUIPMENT FOR MONITORING SYNTROPHIC RELATIONS IN A BIOLOGICAL PROCESS FLUID - A method and an equipment for monitoring the syntrophic relations between different parts of a bacterial consortium in the process fluid of a biological process plant, such as a biological gas plant or waste water treatment plant, through a chromatographic measurement of the content of the individual volatile fatty acids in consecutive samples of the process fluid, the samples being acidified and filtered prior to the chromatographic separation | 09-11-2008 |
Birgitte Kiaer Ahring, Hørsholm DK
Philip K. Ahring, Bagsvnerd DK
| Patent application number | Description | Published |
|---|---|---|
| 20090036476 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX - This invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith. | 02-05-2009 |
Philip K. Ahring, Ballerup DK
| Patent application number | Description | Published |
|---|---|---|
| 20080227772 | Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands - This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. | 09-18-2008 |
| 20100130482 | DIAZABICYCLIC ARYL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS - This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. | 05-27-2010 |
| 20100130483 | NOVEL DIAZABICYCLIC ARYL DERIVATIVES - This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. | 05-27-2010 |
Philip K. Ahring, Bagsv?rd DK
| Patent application number | Description | Published |
|---|---|---|
| 20110257210 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX - The present application discloses novel benzimidazole derivatives of general formula (I) or an N-oxide thereof, any of its stereoisomers or any mixture of its stereoisomers, or a pharmaceutically acceptable salt thereof, wherein R represents a pyridyl or pyrimidyl group; which pyridyl or pyrimidyl group is optionally substituted with one or more substituents independently selected from the group consisting of: halo, trifluoromethyl, trifluoromethoxy, cyano, nitro, alkyl, hydroxy, hydroxyalkyl and alkoxy, and their use as modulators of the GABA | 10-20-2011 |
Phillip K. Ahring, Ballerup DK
| Patent application number | Description | Published |
|---|---|---|
| 20090005390 | NOVEL QUINUCLIDINE DERIVATIVES AND THEIR USE - This invention relates to novel quinuclidine derivatives and their use as pharmaceuticals. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances. | 01-01-2009 |